Roche's Kadcyla set for EU launch, perhaps in Germany
This article was originally published in Scrip
Executive Summary
Roche is preparing to launch HER2 positive breast cancer antibody-drug conjugate Kadcyla (trastuzumab emtansine) in Europe following approval from the European Commission.